AIRLINK 200.75 Increased By ▲ 7.19 (3.71%)
BOP 10.21 Increased By ▲ 0.26 (2.61%)
CNERGY 7.71 Decreased By ▼ -0.22 (-2.77%)
FCCL 40.06 Decreased By ▼ -0.59 (-1.45%)
FFL 16.81 Decreased By ▼ -0.05 (-0.3%)
FLYNG 26.65 Decreased By ▼ -1.10 (-3.96%)
HUBC 132.60 Increased By ▲ 0.02 (0.02%)
HUMNL 13.92 Increased By ▲ 0.03 (0.22%)
KEL 4.65 Increased By ▲ 0.05 (1.09%)
KOSM 6.59 Decreased By ▼ -0.03 (-0.45%)
MLCF 46.74 Decreased By ▼ -0.86 (-1.81%)
OGDC 212.43 Decreased By ▼ -1.48 (-0.69%)
PACE 6.90 Decreased By ▼ -0.03 (-0.43%)
PAEL 41.28 Increased By ▲ 0.04 (0.1%)
PIAHCLA 17.00 Decreased By ▼ -0.15 (-0.87%)
PIBTL 8.11 Decreased By ▼ -0.30 (-3.57%)
POWER 9.42 Decreased By ▼ -0.22 (-2.28%)
PPL 181.46 Decreased By ▼ -0.89 (-0.49%)
PRL 41.78 Decreased By ▼ -0.18 (-0.43%)
PTC 24.70 Decreased By ▼ -0.20 (-0.8%)
SEARL 111.84 Increased By ▲ 5.00 (4.68%)
SILK 1.00 Increased By ▲ 0.01 (1.01%)
SSGC 43.92 Increased By ▲ 3.82 (9.53%)
SYM 18.98 Increased By ▲ 1.51 (8.64%)
TELE 8.87 Increased By ▲ 0.03 (0.34%)
TPLP 12.92 Increased By ▲ 0.17 (1.33%)
TRG 67.47 Increased By ▲ 0.52 (0.78%)
WAVESAPP 11.42 Increased By ▲ 0.09 (0.79%)
WTL 1.79 No Change ▼ 0.00 (0%)
YOUW 3.99 Decreased By ▼ -0.08 (-1.97%)
BR100 12,170 Increased By 125.6 (1.04%)
BR30 36,589 Increased By 8.6 (0.02%)
KSE100 114,880 Increased By 842.7 (0.74%)
KSE30 36,125 Increased By 330.6 (0.92%)

Professor Dr Khalid M Khan senior scientist in the Karachi University's International Center for Chemical and Biological Sciences (ICCBS), has been nominated for Sitara-e- Imtiaz here on Saturday. Dr Khan is among the most prominent researchers of Pakistan.
He was awarded Justice Qadeeruddin Gold Medal in 2003 and Pakistan Academy of Sciences Gold Medal in 2004. The President of Pakistan has awarded Tamgha-i-Imtiaz in recognition of his research work in the field of bio-organic and medicinal chemistry in the year 2004. He is working in HEJ Research Institute of Chemistry since 1987.
He is currently working as a professor in HEJ Research Institute. The major emphasis of his work is on the synthesis of inhibitors of clinically important enzymes. He currently identified a number of new lead compounds, which are active against leishmaniasis (Kala- Azar) and peptic ulcer.

Copyright Business Recorder, 2011

Comments

Comments are closed.